Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic Pain

NCT07159243 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Peripheral Neuropathic Pain

Interventions

DRUG: HL-1186
DRUG: HL-1186
DRUG: HL-1186 placebo

Sponsor

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.